Seeking Alpha EN

Clene GAAP EPS of -$2.65, revenue of $0.2M

Mar 12, 2026 &03071212202631; 19:07 UTC seekingalpha.com Trending 4/5

Read original on seekingalpha.com ↗

↘

Negative for markets

Sentiment score: -85/100

High impact Immediate effect (hours)

WHAT THIS MEANS

Clene reported a significant GAAP loss of -$2.65 per share with minimal revenue of only $0.2M, indicating severe operational challenges and cash burn concerns. The company is struggling with profitability and revenue generation, raising questions about its business viability and runway.

AI CONFIDENCE

90% Very high

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↓

CLNE

CLNEStock

Expected to decline

Massive EPS loss of -$2.65 with negligible revenue of $0.2M signals severe financial distress and operational failure

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Avoid or exit positions in CLNE immediately. The company shows critical financial weakness with unsustainable losses and minimal revenue generation. Monitor for potential bankruptcy filing or dilutive capital raises.

KEY SIGNALS

Extreme negative EPSRevenue collapse or minimal commercializationHigh cash burn ratePotential going concern issuesShareholder dilution risk

SECTORS INVOLVED

Healthcare/BiotechSmall Cap

Analysis generated on Mar 16, 2026 at 16:30 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Clene GAAP EPS of -$2.65, revenue of $0.2M

RELATED INTELLIGENCE